These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 20088170

  • 1. [Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].
    Muslimović A, Rasić S, Rebić D, Uncanin S.
    Med Arh; 2009; 63(4):187-90. PubMed ID: 20088170
    [Abstract] [Full Text] [Related]

  • 2. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
    Kosmadakis G, Filiopoulos V, Smirloglou D, Skarlas P, Georgoulias C, Michail S.
    Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
    [Abstract] [Full Text] [Related]

  • 3. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 4. Treatment aspects of primary nephrotic syndrome in adults.
    Rasić S, Uncanin S, Dzemidzić J, Aganović K, Srna A, Rasić I.
    Bosn J Basic Med Sci; 2006 May; 6(2):16-20. PubMed ID: 16879107
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

  • 6. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
    Tao JL, Liu LL, Wen YB, Gao RT, Li H, Li MX, Li XM, Li XW.
    Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 Nov; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 9. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Nov; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 11. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005 Jul; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 13. Membranous glomerulonephritis: treatment response and outcome in children.
    Valentini RP, Mattoo TK, Kapur G, Imam A.
    Pediatr Nephrol; 2009 Feb; 24(2):301-8. PubMed ID: 18846392
    [Abstract] [Full Text] [Related]

  • 14. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.
    J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 16. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 17. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V.
    J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
    [Abstract] [Full Text] [Related]

  • 18. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990 Jun; 29(3):53-60. PubMed ID: 2284800
    [Abstract] [Full Text] [Related]

  • 19. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C, Li H, Wen YB, Li JN, Lin WF, Cai JF, Duan L, Li Y, Li XM, Li XW.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug 20; 39(4):544-551. PubMed ID: 28877834
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.